# Juno Therapeutics, Inc. – FDA Inspection, Sep 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/juno-therapeutics-inc/788615a3-a24c-4b20-a025-fd3cb9aeea6c
Source feed: FDA_Inspections

> FDA inspection 1218201 of Juno Therapeutics, Inc., September 20, 2023. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218201
- Company Name: Juno Therapeutics, Inc.
- Inspection Date: 2023-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1287586 - 2025-11-04
- FDA Inspection 1229984 - 2024-09-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [Company Rep](https://www.keypedia.com/people/michael-araneta/c94c95f4-2cda-43f5-a02a-2b5d82fe2c7d)

Company: https://www.keypedia.com/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
